| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,844 |
2,432 |
$218K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,976 |
3,382 |
$195K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,648 |
1,336 |
$126K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
795 |
682 |
$54K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
293 |
270 |
$41K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
413 |
367 |
$31K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,313 |
1,115 |
$21K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
627 |
597 |
$15K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
329 |
233 |
$12K |
| 96160 |
|
504 |
394 |
$7K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
20 |
16 |
$7K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
272 |
164 |
$5K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
54 |
43 |
$5K |
| 90698 |
|
349 |
299 |
$4K |
| 90670 |
|
384 |
340 |
$4K |
| 90686 |
|
376 |
321 |
$4K |
| 96127 |
|
212 |
183 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
210 |
194 |
$3K |
| 83655 |
|
242 |
207 |
$3K |
| D1206 |
Topical application of fluoride varnish |
103 |
102 |
$3K |
| 92551 |
|
164 |
134 |
$2K |
| 99174 |
|
329 |
249 |
$2K |
| 85018 |
|
949 |
796 |
$2K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
30 |
30 |
$1K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
22 |
13 |
$1K |
| 36416 |
|
240 |
209 |
$971.70 |
| 90651 |
|
13 |
13 |
$902.68 |
| 90671 |
|
49 |
38 |
$895.24 |
| 90661 |
|
45 |
39 |
$751.95 |
| 90674 |
|
39 |
35 |
$651.69 |
| 90680 |
|
72 |
64 |
$486.40 |
| 99173 |
|
65 |
53 |
$484.25 |
| 90700 |
|
36 |
30 |
$427.52 |
| 90744 |
|
43 |
38 |
$300.80 |
| 90647 |
|
21 |
15 |
$232.96 |
| 90633 |
|
19 |
16 |
$121.60 |